Claudia Stöllberger

Prof. Claudia Stöllberger

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2002 in The American Journal of Cardiology
Verified
Journal Article
Closed access
CSClaudia Stöllberger
Claudia Stöllberger
JFJosef Finsterer
Josef Finsterer
GBGerhard Blazek
Gerhard Blazek

1 January 2004 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
CSClaudia Stöllberger
Claudia Stöllberger
JFJosef Finsterer
Josef Finsterer

1 September 2005 in International Clinical Psychopharmacology
Verified
Journal Article
Closed access
CSClaudia Stöllberger
Claudia Stöllberger
JHJohannes O. Huber
Johannes O. Huber
JFJosef Finsterer
Josef Finsterer
Antipsychotic drugs (AD) are effective and frequently prescribed to more females than males. AD may cause serious cardiovascular side-effects, including prolonged QT interval, eventually leading to torsades de pointes (TdP) and sudden death. Epidemiologic data and case–control studies indicate an increased rate of sudden death in psychiatric patients taking AD. This review summarizes current knowledge about the QT prolonging effects of AD and gives practical suggestions. Amisulpride, clozapine, flupenthixol, fluphenazine, haloperidol, melperone, olanzapine, perphenazine, pimozide, quetiapine, risperidone, sulpiride, thioridazine and ziprasidone cause a QT prolongation ranging from 4 ms for risperidone to 30 ms for thioridazine. Our knowledge about the QT-prolonging effects of many AD is still limited. Females are under-represented in most studies. Many studies were conducted or supported by pharmaceutical companies. To avoid prodysrhythmia caused by QT prolongation, other factors influencing QT interval have to be considered, such as other drugs affecting the same pathway, hypokalemia, hypomagnesemia, bradycardia, increased age, female sex, congestive heart failure and polymorphisms of genes coding ion channels or enzymes involved in drug metabolism. Because the response of a patient to AD is individual, an electrocardiogram recording the QT interval has to be performed at baseline, after AD introduction and after occurrence of any factor that might influence the QT interval.

1 October 2011 in The American Journal of Cardiology
Verified
Journal Article
Closed access
CSClaudia Stöllberger
Claudia Stöllberger
GBGerhard Blazek
Gerhard Blazek
CDChristoph Dobias
Christoph Dobias
AHAileen Hanafin
Aileen Hanafin
CWChristian Wegner
Christian Wegner
JFJosef Finsterer
Josef Finsterer

1 May 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
CSClaudia Stöllberger
Claudia Stöllberger
BGBirgit Gerecke
Birgit Gerecke
JFJosef Finsterer
Josef Finsterer
RERolf Engberding
Rolf Engberding

1 December 2003 in Chest
Verified
Journal Article
Closed access
CSClaudia Stöllberger
Claudia Stöllberger
BSBirke Schneider
Birke Schneider
JFJosef Finsterer
Josef Finsterer